Literature DB >> 8324904

Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.

K Broliden1, E Sievers, P A Tovo, V Moschese, G Scarlatti, P A Broliden, C Fundaro, P Rossi.   

Abstract

The prognostic and protective role of antibodies mediating cellular cytotoxicity (ADCC) and neutralization was evaluated in sera of HIV-1-infected mothers and their consecutively followed children. The presence and titres of ADCC mediating and/or neutralizing antibodies in maternal sera did not predict HIV-1 infection in their respective children. No significant difference in the sera from the children was seen when comparing the presence of neutralizing antibodies between the uninfected and infected children. Stratification of the infected group according to clinical status revealed differences. Only one of 24 AIDS patients had a high neutralizing titre against IIIB. Four patients had a very low titre and the remaining had no detectable neutralizing antibodies at all. In contrast, 10/17 infected non-AIDS children had neutralizing antibodies. Similarly, no significant difference was seen when comparing the presence of ADCC-mediating antibodies between the uninfected and the infected group of children. However, a significantly higher frequency of ADCC was seen in the seropositive non-AIDS children compared with the AIDS children. This study clearly shows that the presence of antibodies mediating ADCC and neutralization in infected children, 0-2 years old, is associated with a better clinical status and delayed disease progression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324904      PMCID: PMC1554739          DOI: 10.1111/j.1365-2249.1993.tb06497.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Characterization of HIV-1 neutralization escape mutants.

Authors:  J A McKeating; J Gow; J Goudsmit; L H Pearl; C Mulder; R A Weiss
Journal:  AIDS       Date:  1989-12       Impact factor: 4.177

2.  Does infection with HIV affect the outcome of pregnancy?

Authors:  F D Johnstone; L MacCallum; R Brettle; J M Inglis; J F Peutherer
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-13

3.  HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission.

Authors:  W Maury; B J Potts; A B Rabson
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

4.  Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.

Authors:  P Rossi; V Moschese; P A Broliden; C Fundaró; I Quinti; A Plebani; C Giaquinto; P A Tovo; K Ljunggren; J Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa.

Authors:  A G Poulsen; B Kvinesdal; P Aaby; K Mølbak; K Frederiksen; F Dias; E Lauritzen
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

6.  Survival in children with perinatally acquired human immunodeficiency virus type 1 infection.

Authors:  G B Scott; C Hutto; R W Makuch; M T Mastrucci; T O'Connor; C D Mitchell; E J Trapido; W P Parks
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

7.  Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.

Authors:  K Ljunggren; V Moschese; P A Broliden; C Giaquinto; I Quinti; E M Fenyö; B Wahren; P Rossi; M Jondal
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

8.  Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group.

Authors:  M F Rogers; C Y Ou; M Rayfield; P A Thomas; E E Schoenbaum; E Abrams; K Krasinski; P A Selwyn; J Moore; A Kaul
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

9.  Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.

Authors:  R S Blumberg; T Paradis; K L Hartshorn; M Vogt; D D Ho; M S Hirsch; J Leban; V L Sato; R T Schooley
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

10.  Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.

Authors:  V A Sundqvist; J Albert; E Ohlsson; J Hinkula; E M Fenyö; B Wahren
Journal:  J Med Virol       Date:  1989-11       Impact factor: 2.327

View more
  21 in total

Review 1.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

Review 2.  Role of Fc-mediated antibody function in protective immunity against HIV-1.

Authors:  George K Lewis
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

3.  Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope.

Authors:  Leslie Goo; Caitlin Milligan; Cassandra A Simonich; Ruth Nduati; Julie Overbaugh
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.

Authors:  Caitlin Milligan; Barbra A Richardson; Grace John-Stewart; Ruth Nduati; Julie Overbaugh
Journal:  Cell Host Microbe       Date:  2015-04-08       Impact factor: 21.023

5.  Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Authors:  Ashley N Nelson; Ria Goswami; Maria Dennis; Joshua Tu; Riley J Mangan; Pooja T Saha; Derek W Cain; Alan D Curtis; Xiaoying Shen; George M Shaw; Katharine Bar; Michael Hudgens; Justin Pollara; Kristina De Paris; Koen K A Van Rompay; Sallie R Permar
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

6.  Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses.

Authors:  C Hutto; Y Zhou; J He; R Geffin; M Hill; W Scott; C Wood
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 7.  Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.

Authors:  David R Martinez; Sallie R Permar; Genevieve G Fouda
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

8.  Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.

Authors:  Maxwel M Omenda; Caitlin Milligan; Katherine Odem-Davis; Ruth Nduati; Barbra A Richardson; John Lynch; Grace John-Stewart; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

9.  Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

Authors:  A Mabondzo; P Rouvier; H Raoul; R Le Naour; C Courpotin; F Hervé; F Parnet-Mathieu; G Lasfargues; D Dormont
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 10.  The role of Fc receptors in HIV prevention and therapy.

Authors:  Austin W Boesch; Eric P Brown; Margaret E Ackerman
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.